{"id":"https://openalex.org/W4393988674","doi":"https://doi.org/10.1158/1538-7445.am2024-ct030","title":"Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre-conditioning regimen on the microbiome and immunity","display_name":"Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre-conditioning regimen on the microbiome and immunity","publication_year":2024,"publication_date":"2024-04-05","ids":{"openalex":"https://openalex.org/W4393988674","doi":"https://doi.org/10.1158/1538-7445.am2024-ct030"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-ct030","doi":"https://doi.org/10.1158/1538-7445.am2024-ct030","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-ct030","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019203117","display_name":"Isabella C. Glitza Oliva","orcid":"https://orcid.org/0000-0002-4530-7765","observed_orcids":["https://orcid.org/0000-0002-4530-7765"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isabella C. Glitza Oliva","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073658575","display_name":"Yongwoo David Seo","orcid":"https://orcid.org/0000-0001-6837-5018","observed_orcids":["https://orcid.org/0000-0001-6837-5018"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongwoo David Seo","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022333320","display_name":"Christine N. Spencer","orcid":"https://orcid.org/0000-0002-1304-4390","observed_orcids":["https://orcid.org/0000-0002-1304-4390","https://orcid.org/0000-0002-3287-0292"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine N. Spencer","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022460492","display_name":"Jennifer Russo Wortman","orcid":"https://orcid.org/0000-0002-8713-1227","observed_orcids":["https://orcid.org/0000-0002-8713-1227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer R. Wortman","raw_affiliation_strings":["3Seres Therapeutics, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Seres Therapeutics, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036227254","display_name":"Elizabeth M. Burton","orcid":"https://orcid.org/0000-0002-3424-4922","observed_orcids":["https://orcid.org/0000-0002-3424-4922"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth M. Burton","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065491601","display_name":"Farah A. Alayli","orcid":"https://orcid.org/0009-0003-1155-1756","observed_orcids":["https://orcid.org/0009-0003-1155-1756"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farah A. Alayli","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058423360","display_name":"Christopher P. Loo","orcid":"https://orcid.org/0000-0002-5302-8774","observed_orcids":["https://orcid.org/0000-0002-5302-8774"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Loo","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068470371","display_name":"Shikha Gautam","orcid":"https://orcid.org/0000-0003-4885-7823","observed_orcids":["https://orcid.org/0000-0003-4885-7823"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shikha Gautam","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067197750","display_name":"Ashish V. Damania","orcid":"https://orcid.org/0009-0001-3158-2846","observed_orcids":["https://orcid.org/0009-0001-3158-2846"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish V. Damania","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053210608","display_name":"Julie Densmore","orcid":"https://orcid.org/0009-0006-0191-1780","observed_orcids":["https://orcid.org/0009-0006-0191-1780"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Densmore","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070664118","display_name":"Justin P. Fairchild","orcid":"https://orcid.org/0000-0002-4478-7146","observed_orcids":["https://orcid.org/0000-0002-4478-7146"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Fairchild","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049359065","display_name":"Christopher R. Cabanski","orcid":"https://orcid.org/0009-0007-9938-1331","observed_orcids":["https://orcid.org/0009-0007-9938-1331"]},"institutions":[{"id":"https://openalex.org/I4210109986","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210109986"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Cabanski","raw_affiliation_strings":["2Parker Institute for Cancer Immunotherapy, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Parker Institute for Cancer Immunotherapy, San Francisco, CA;","institution_ids":["https://openalex.org/I4210109986"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021359962","display_name":"Matthew C. Wong","orcid":"https://orcid.org/0000-0002-6317-2526","observed_orcids":["https://orcid.org/0000-0002-6317-2526"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew C. Wong","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090179091","display_name":"Christine B. Peterson","orcid":"https://orcid.org/0000-0003-3316-0468","observed_orcids":["https://orcid.org/0000-0003-3316-0468"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine B. Peterson","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034798965","display_name":"Brian Weiner","orcid":"https://orcid.org/0000-0002-7285-4385","observed_orcids":["https://orcid.org/0000-0002-7285-4385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Weiner","raw_affiliation_strings":["3Seres Therapeutics, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Seres Therapeutics, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011528491","display_name":"Nathan D. Hicks","orcid":"https://orcid.org/0000-0002-6631-8383","observed_orcids":["https://orcid.org/0000-0002-6631-8383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathan Hicks","raw_affiliation_strings":["3Seres Therapeutics, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Seres Therapeutics, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036398869","display_name":"John G Aunins","orcid":"https://orcid.org/0000-0001-7499-7948","observed_orcids":["https://orcid.org/0000-0001-7499-7948"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Aunins","raw_affiliation_strings":["3Seres Therapeutics, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Seres Therapeutics, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073457542","display_name":"Christopher W. J. McChalicher","orcid":"https://orcid.org/0000-0002-6179-9886","observed_orcids":["https://orcid.org/0000-0002-6179-9886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher McChalicher","raw_affiliation_strings":["3Seres Therapeutics, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Seres Therapeutics, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067831105","display_name":"Michael T. Tetzlaff","orcid":"https://orcid.org/0000-0001-7899-4138","observed_orcids":["https://orcid.org/0000-0001-7899-4138"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael T. Tetzlaff","raw_affiliation_strings":["4University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028592995","display_name":"Omid Hamid","orcid":"https://orcid.org/0000-0002-8238-4655","observed_orcids":["https://orcid.org/0000-0002-8238-4655"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omid Hamid","raw_affiliation_strings":["5Cedars Sinai Research Institute, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Cedars Sinai Research Institute, Los Angeles, CA;","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041066193","display_name":"Patrick Alexander Ott","orcid":"https://orcid.org/0000-0002-4253-943X","observed_orcids":["https://orcid.org/0000-0002-4253-943X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick A. Ott","raw_affiliation_strings":["6Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009222009","display_name":"Genevieve Marie Boland","orcid":"https://orcid.org/0000-0002-7522-6173","observed_orcids":["https://orcid.org/0000-0002-7522-6173"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Genevieve M. Boland","raw_affiliation_strings":["7Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan J. Sullivan","raw_affiliation_strings":["7Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073549408","display_name":"Kenneth F. Grossmann","orcid":"https://orcid.org/0000-0002-8523-7407","observed_orcids":["https://orcid.org/0000-0002-8523-7407"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth F. Grossmann","raw_affiliation_strings":["8Merck & Co, Rahway, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Merck & Co, Rahway, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021359372","display_name":"Nadim J. Ajami","orcid":"https://orcid.org/0000-0002-3808-8576","observed_orcids":["https://orcid.org/0000-0002-3808-8576"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadim J. Ajami","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066301151","display_name":"Theresa M. LaVallee","orcid":"https://orcid.org/0000-0002-1769-3195","observed_orcids":["https://orcid.org/0000-0002-1769-3195"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theresa M. LaVallee","raw_affiliation_strings":["9Coherus BioSciences, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Coherus BioSciences, Redwood City, CA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016390534","display_name":"Matthew R. Henn","orcid":"https://orcid.org/0000-0001-8734-5797","observed_orcids":["https://orcid.org/0000-0001-8734-5797"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew R. Henn","raw_affiliation_strings":["3Seres Therapeutics, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Seres Therapeutics, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000768609","display_name":"Hussein A. Tawbi","orcid":"https://orcid.org/0000-0003-1942-851X","observed_orcids":["https://orcid.org/0000-0003-1942-851X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hussein A. Tawbi","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035427219","display_name":"Jennifer Ann Wargo","orcid":"https://orcid.org/0000-0003-3438-7576","observed_orcids":["https://orcid.org/0000-0003-3438-7576"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Wargo","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"7_Supplement","first_page":"CT030","last_page":"CT030"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":0.03099999949336052,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/gut-microbiota-modulation","display_name":"gut microbiota modulation","score":0.8870000243186951},{"id":"https://openalex.org/keywords/bacterial-consortia","display_name":"bacterial consortium","score":0.6669999957084656},{"id":"https://openalex.org/keywords/ruminococcaceae","display_name":"Ruminococcaceae","score":0.8220000267028809},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7279999852180481},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/butyrate-production","display_name":"butyrate production","score":0.6549999713897705},{"id":"https://openalex.org/keywords/biomarker-stratified-trial","display_name":"biomarker-stratified trial","score":0.6579999923706055},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C143121216","wikidata":"https://www.wikidata.org/wiki/Q1330402","display_name":"Microbiome","level":2,"score":0.7946093082427979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6123682856559753},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.558891773223877},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.528121829032898},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5024638175964355},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48607662320137024},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.4559633433818817},{"id":"https://openalex.org/C3019978661","wikidata":"https://www.wikidata.org/wiki/Q739734","display_name":"Gut microbiome","level":3,"score":0.4519970417022705},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.427154004573822},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4228115975856781},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4153466820716858},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3583912253379822},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22528895735740662},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17511162161827087},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.1640826165676117},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.14435240626335144},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.11721429228782654},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-ct030","doi":"https://doi.org/10.1158/1538-7445.am2024-ct030","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-ct030","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8100000023841858}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2994966085","https://openalex.org/W4293056667","https://openalex.org/W3044286215","https://openalex.org/W4213248990","https://openalex.org/W2621141937","https://openalex.org/W4312476285","https://openalex.org/W2793187602","https://openalex.org/W3044328089","https://openalex.org/W3016347906","https://openalex.org/W2333607221"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Gut":[2],"microbiota":[3],"modulation":[4,291,444],"shows":[5],"promise":[6],"in":[7,36,67,182,206,239,251,268,302,348],"improving":[8],"immune":[9],"checkpoint":[10],"blockade":[11],"(ICB)":[12],"response;":[13],"however,":[14],"precision":[15,352],"biomarker-driven":[16,289,343],"trials":[17,345],"using":[18,44],"rationally-designed":[19],"consortia":[20,48],"are":[21,298,346],"lacking.":[22],"To":[23],"address":[24],"this,":[25],"we":[26],"performed":[27],"a":[28,46,58,236,249,299],"multi-center,":[29,59],"randomized":[30,74,158,288],"placebo-controlled,":[31,287,439],"biomarker-stratified":[32,440],"phase":[33,64,441],"1":[34,194],"trial":[35,292,445],"patients":[37,68,156],"with":[38,69,126,174,193,199,203,211,232],"ICB-na\u00efve":[39],"unresectable":[40],"or":[41,80],"metastatic":[42,447],"melanoma":[43,303,448],"SER-401,":[45],"bacterial":[47],"enriched":[49],"for":[50,150,446,467],"Firmicutes":[51],"spores":[52],"and":[53,62,84,111,118,141,170,189,223,248,296,328,458,478],"Ruminococcaceae.":[54],"Methods:":[55],"MCGRAW":[56],"was":[57,124,147,168,172,187,191,201,235,265,307],"randomized,":[60],"blinded,":[61],"placebo-controlled":[63,342],"1b":[65,442],"study":[66,146,306],"advanced":[70],"melanoma.":[71],"Patients":[72,91],"were":[73,114,157,319],"2:1":[75],"to":[76],"the":[77,164,183,207,313,456,464],"SER-401":[78,295],"active":[79],"placebo":[81,102,184],"arm,":[82,166,185],"respectively,":[83],"stratified":[85],"by":[86,107,227,261,279,309],"baseline":[87,117],"stool":[88],"Ruminococcaceae":[89,218],"abundance.":[90],"received":[92],"an":[93],"oral":[94],"vancomycin":[95],"(vanco)":[96],"preparative":[97],"regimen+SER-401":[98],"(vanco+SER-401":[99],"arm),":[100,105],"versus":[101],"antibiotic+placebo":[103],"(Placebo":[104],"followed":[106,226],"nivolumab.":[108],"Stool,":[109],"blood":[110],"tumor":[112],"samples":[113],"collected":[115],"at":[116],"on":[119,455],"treatment.":[120],"The":[121,145,305],"primary":[122],"endpoint":[123],"safety,":[125],"additional":[127],"secondary":[128],"endpoints":[129],"(SER-401":[130],"microbiome":[131,208,290,344,443,457],"engraftment,":[132],"overall":[133],"response":[134],"rate":[135,139],"(ORR),":[136],"disease":[137],"control":[138],"(DCR),":[140],"other":[142,224],"translational":[143,322],"endpoints).":[144],"not":[148],"powered":[149],"comparison":[151],"between":[152],"arms.":[153],"Results:":[154],"14":[155],"(n=8":[159],"vanco+SER-401,":[160],"n=6":[161],"placebo).":[162],"In":[163],"vanco+SER-401":[165],"ORR":[167,186],"25.0%":[169],"DCR":[171,190],"37.5%,":[173],"no":[175],"Grade":[176],"3-4":[177],"treatment-related":[178],"adverse":[179],"events":[180],"(TRAE);":[181],"66.7%":[188],"83.3%,":[192],"(17%)":[195],"TRAE.":[196],"Notably,":[197],"pre-conditioning":[198,453],"vanco":[200,255],"associated":[202,242],"significant":[204,237],"shift":[205],"taxonomic":[209],"composition,":[210],"depletion":[212],"of":[213,272,282,351,451,463],"target":[214],"families":[215],"such":[216,339],"as":[217],"(p=0.008,":[219],"Wilcoxon":[220],"signed-rank":[221],"test),":[222],"spore-formers,":[225],"their":[228],"recovery":[229],"post":[230],"dosing":[231,331],"SER-401.":[233],"There":[234,264],"increase":[238,267],"multiple":[240],"ICB-resistance":[241],"pathways":[243,253],"(e.g.":[244],"butyrate":[245],"synthesis,":[246],"p<0.0001),":[247],"decrease":[250],"response-associated":[252],"after":[254,274],"preconditioning;":[256],"these":[257],"changes":[258],"did":[259],"normalize":[260],"nivolumab":[262],"initiation.":[263],"corresponding":[266],"systemic":[269],"proteomic":[270],"markers":[271],"inflammation":[273],"vanco,":[275],"which":[276],"also":[277],"normalized":[278],"first":[280],"dose":[281],"immunotherapy.":[283],"Conclusions:":[284],"This":[285],"first-of-its-kind,":[286],"demonstrated":[293],"that":[294,325],"anti-PD1":[297],"safe":[300],"combination":[301],"patients.":[304],"limited":[308],"poor":[310],"accrual":[311],"during":[312],"COVID-19":[314],"pandemic.":[315],"Nonetheless,":[316],"important":[317],"insights":[318],"gained":[320],"via":[321],"analyses,":[323],"suggesting":[324],"antibiotic":[326,452],"preconditioning":[327],"interventional":[329],"drug":[330],"regimens":[332],"should":[333],"be":[334],"carefully":[335],"considered":[336],"when":[337],"designing":[338],"trials.":[340],"Additional":[341],"needed":[347],"this":[349],"age":[350],"medicine.":[353],"Trial":[354],"registration:":[355],"ClinicalTrials.gov":[356],"(NCT03817125)":[357],"Citation":[358],"Format:":[359],"Isabella":[360],"C.":[361,393],"Glitza":[362],"Oliva,":[363],"Yongwoo":[364],"David":[365],"Seo,":[366],"Christine":[367,395],"N.":[368],"Spencer,":[369],"Jennifer":[370,435],"R.":[371,430],"Wortman,":[372],"Elizabeth":[373],"M.":[374,415,427],"Burton,":[375],"Farah":[376],"A.":[377,412,433,436],"Alayli,":[378],"Christopher":[379,390,404],"Loo,":[380],"Shikha":[381],"Gautam,":[382],"Ashish":[383],"V.":[384],"Damania,":[385],"Julie":[386],"Densmore,":[387],"Justin":[388],"Fairchild,":[389],"Cabanski,":[391],"Matthew":[392,429],"Wong,":[394],"B.":[396],"Peterson,":[397],"Brian":[398],"Weiner,":[399],"Nathan":[400],"Hicks,":[401],"John":[402],"Aunins,":[403],"McChalicher,":[405],"Michael":[406],"T.":[407],"Tetzlaff,":[408],"Omid":[409],"Hamid,":[410],"Patrick":[411],"Ott,":[413],"Genevieve":[414],"Boland,":[416],"Ryan":[417],"J.":[418,424],"Sullivan,":[419],"Kenneth":[420],"F.":[421],"Grossmann,":[422],"Nadim":[423],"Ajami,":[425],"Theresa":[426],"LaVallee,":[428],"Henn,":[431],"Hussein":[432],"Tawbi,":[434],"Wargo.":[437],"Randomized":[438],"demonstrates":[449],"impact":[450],"regimen":[454],"immunity":[459],"[abstract].":[460],"In:":[461],"Proceedings":[462],"American":[465],"Association":[466],"Cancer":[468,490],"Research":[469],"Annual":[470],"Meeting":[471],"2024;":[472],"Part":[473],"2":[474],"(Late-Breaking,":[475],"Clinical":[476],"Trial,":[477],"Invited":[479],"Abstracts);":[480],"2024":[481],"Apr":[482],"5-10;":[483],"San":[484],"Diego,":[485],"CA.":[486],"Philadelphia":[487],"(PA):":[488],"AACR;":[489],"Res":[491],"2024;84(7_Suppl):Abstract":[492],"nr":[493],"CT030.":[494]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}